Results 271 to 280 of about 4,146,035 (404)
TRIM24 and TRIM28 are androgen receptor (AR) coregulators which exhibit increased expression with cancer progression. Both TRIM24 and TRIM28 combine to influence the response of castrate‐resistant prostate cancer (CRPC) cells to AR inhibitors by mediating AR signalling, regulation of MYC and upregulating VEGF to promote angiogenesis. Castrate‐resistant
Damien A. Leach+8 more
wiley +1 more source
Exploring miR-301a-3p and osteosarcoma: from expression differences to mechanism of action. [PDF]
Liu T, Ma M.
europepmc +1 more source
ON THE MECHANISM OF COCARBOXYLASE ACTION; A REINVESTIGATION
Kurt G. Stern, Joseph L. Melnick
openalex +1 more source
A DIA‐MS‐based proteomics analysis of serum samples from GB patients and healthy controls showed that high levels of IL1R2 and low levels of CRTAC1 and HRG in serum are associated with poor survival outcomes for GB patients. These circulating proteins could serve as biomarkers for the prediction of outcome in patients with GB.
Anne Clavreul+11 more
wiley +1 more source
Cross modality learning of cell painting and transcriptomics data improves mechanism of action clustering and bioactivity modelling. [PDF]
Ha SV+5 more
europepmc +1 more source
Unique features of trabectedin mechanism of action
A. Larsen, C. Galmarini, M. D’Incalci
semanticscholar +1 more source
Non‐small cell lung cancer targeted treatment is limited to a few known genetic alterations, with few alternatives in advanced treatment lines. To direct treatment decisions by drug sensitivity testing (DST), this study compared several methods for tumor cell isolation from malignant effusions, pointing to repeated CD45+ cell depletion for effective ...
Navit Mooshayef+10 more
wiley +1 more source
Elucidation of Mechanism of Action in Drug Invention: Using Stable Isotope Tracers to Unravel Biochemical Kinetics. [PDF]
Kohnz RA+10 more
europepmc +1 more source